rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ACON
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Aclarion Announces New Real-World Publication: Nociscan® Validated by Strong Agreement with Discography in Diagnosing Painful Lumbar Discs
      Oct 22Yahoo FinanceACON
      Aclarion at LD Micro main event: pushing Nociscan toward scale
      Oct 20Investing.comACON
      Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026

      85% year-over-year scan volume growth in Q3 2026, contributing to 117% growth for the nine months ended September 30, 2026European Spine Journal publishes peer-reviewed data supporting MRS as a potential viable alternative to provocative discographyCLARITY trial expanded to eleven clinical sites with updated enrollment criteria to accelerate recruitmentOverall CLARITY trial duration remains on track, with an update on enrollment progress and anticipated initial readout timing by year-end$14.2 mi

      Oct 20Yahoo FinanceACON
      Aclarion to Present at the 20th Annual LD Micro Main Event

      BROOMFIELD, Colo., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Aclarion (NASDAQ: ACON) announced today that it will participate in the 20th Annual LD Micro Main Event, taking place October 19-21, 2026 at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Aclarion is scheduled to present on Tuesday, October 20, 2026 at 11:30 AM PT. Brent Ness, Chief Executive Officer will represent the company. Presentation Details Event: LD Micro Main Event XXDate: Tuesday, October 20, 2026Time: 11:30 AMLocation:

      Oct 13Yahoo FinanceACON
      Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
      Oct 8Yahoo FinanceACON
      Aclarion at Lytham Partners fall investor conference: growth and proof By Investing.com
      Sep 29Investing.comACON
      Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites

      NYU Langone Health is a nationally recognized academic medical center with deep expertise in spine surgery, minimally invasive procedures, robotic spine surgery, and clinical researchCLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., Sep

      Sep 29Yahoo FinanceACON

      This is the newest page. Registered accounts read further back.